Read + Share
Amedeo Smart
Independent Medical Education
Yver A, Agatsuma T, Soria JC. The art of innovation: clinical development of trastuzumab deruxtecan and redefining how antibody-drug conjugates target HER2-positive cancers. Ann Oncol 2020;31:430-434.PMID: 32067685
Email
LinkedIn
Facebook
Twitter
Privacy Policy